Bunnage Mark E.

EVP, Chief Scientific Officer at VRTX

Sold, on record
$3M
Dollars the filings state
Form 4 sales
4
Latest May 15, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • VRTXVERTEX PHARMACEUTICALS INC / MAEVP, Chief Scientific Officer

Sales by reason

4
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale VRTXRoutine
    Feb 11 2026

    Sold 2,021 shares at $460.43 ($931k)

    Bunnage Mark E., EVP, Chief Scientific Officer

    10b5-1 planSold 13.5% of holdings ($6.9M position)12,914 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale VRTXRoutine
    Feb 18 +7 days

    Sold 3,619 shares at $484.31 ($1.8M)

    Bunnage Mark E., EVP, Chief Scientific Officer

    10b5-1 planSold 29.9% of holdings ($5.9M position)8,486 shares leftFiling

  3. 3 Form 4 sale VRTXRoutine
    Feb 25 +7 days

    Sold 620 shares at $486.35 ($302k)

    Bunnage Mark E., EVP, Chief Scientific Officer

    10b5-1 planSold 7.8% of holdings ($3.8M position)7,284 shares leftFiling

  4. 4 Form 4 sale VRTXRoutine
    May 15 +79 days

    Sold 33 shares at $453.45 ($15k)

    Bunnage Mark E., EVP, Chief Scientific Officer

    10b5-1 planSold 0.5% of holdings ($3.3M position)7,284 shares left0x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Bunnage Mark E.
Source
May 15, 2026VRTXEVP, Chief Scientific OfficerForm 4 sale33$15k0.5%RoutineSEC
Feb 25, 2026VRTXEVP, Chief Scientific OfficerForm 4 sale620$302k7.8%RoutineSEC
Feb 18, 2026VRTXEVP, Chief Scientific OfficerForm 4 sale3,619$1.8M29.9%RoutineSEC
Feb 11, 2026VRTXEVP, Chief Scientific OfficerForm 4 sale2,021$931k13.5%RoutineSEC